Laboratory capacity to monitor antiretroviral combination therapy
Laboratory assessment of HIV status and need for treatment is essential to ensure the appropriate and effective use of antiretroviral combination therapy. Monitoring the ability of laboratories to carry out minimal as well as more advanced testing requirements is therefore essential. The purpose of this indicator is therefore to assess the availability of laboratories with the capacity to monitor the people receiving antiretroviral combination therapy according to international guidelines.
The number of designated laboratories with the capacity to monitor antiretroviral combination therapy according to national and international guidelines Laboratories are classified into three levels as follows: • level 1: they meet the minimum testing requirements for testing categories 1 and 2 (above); • level 2: they meet the minimum testing requirements for testing categories 1, 2 and 3; and • level 3: they meet the minimum requirements for all four testing categories.
Total number of designated laboratories
Data will be obtained from a survey of designated laboratories. Data collection will entail observing the availability of functioning equipment and supplies to run the tests at each level.
Every 2-4 years
Condom type: N/A
Geographic location: N/A
HIV status: N/A
Pregnancy status: N/A
Service Type: N/A
Time period: N/A
Type of orphan: N/A
Vulnerability status: N/A
Although this indicator attempts to assess the quality of laboratories by assessing the existence of specific equipment, it does not address human resource needs. Specifically, the presence of a trained laboratory technician available on site to perform the tests required at each level is not currently included.